AD/PD - Advances in Science & Therapy

And...that’s a wrap for #ADPD2026!✨

What an unforgettable few days in Copenhagen - filled with inspiring science, meaningful connections, and incredible moments shared across the global AD/PD™ community. 🧠🌍

Thank you to everyone who joined us - onsite and online - for being part of this journey.

🇪🇸 We can’t wait to see you next year in Barcelona for AD/PD™ 2027!

#Neuroscience #Alzheimers #Parkinsons #NeurodegenerativeDiseases #ADPDCommunity #SeeYouInBarcelona

📰 Hello Lipizone, Unit of 3D Map of Brain Lipids

"Calling all lipid enthusiasts! Scientists have put together a three-dimensional map of where these molecules reside throughout the entire mouse brain. Using high-tech mass-spec imaging, researchers led by Giovanni D’Angelo and Gioele La Manno at the Swiss Federal Institute of Technology - Lausanne, Switzerland, identified 539 distinct clusters of lipids, which they call “lipizones.” The organization largely aligns with known anatomical regions. Some lipizones correspond to certain cell types, while others trace neural connections between distant areas of the brain. Pregnancy remodeled lipizones in the ventricles, choroid plexus, cortex, and white matter."

The study appeared in Nature on September 23.

Continue reading: alzforum.org/news/research-…

The AD/PD™ 2027 Scientific Program brings together speakers from around the world to discuss Alzheimer’s, Parkinson’s, and related disorders. From the molecular signatures of brain function to GBA-1 focused trials in Parkinson’s, the sessions cover both laboratory science and clinical research.

Here is a first look at some of the topics and speakers:
• Molecular Signatures of Brain Function | Tony Wyss-Coray, United States
• GBA-1 Focused Trials in Parkinson’s | Roy N. Alcalay, Israel
• Symptomatic and Disease Modifying Therapy in Parkinson’s Disease | Fabrizio Stocchi, Italy
• Molecular Signaling Pathways Governing Microglial Senescence In Neurodegeneration | Peter St. George-Hyslop, Canada
• Glial Presenilin Function in the Aging Brain | Jie Shen, United States

There’s a lot more in the full program.

Take a look and start planning: adpd.kenes.com/scientific-pro…

#ADPD2027 #Alzheimers #Parkinsons

⏱️ LAST CALL!
Join us tomorrow for a 60-minute live webinar exploring Taudia’s validated 5-plex laboratory-developed test (LDT) and its applications in clinical research.

📅 Tomorrow, 12 November 2026 at 16:00 CET
👉 REGISTER NOW: bit.ly/4jwOD24

Discover the science behind multi-analyte testing, explore Taudia’s SPLASH technology, and gain insights into assay validation and the role of 5-plex testing in AD research.

🚀 SECURE YOUR SPOT AND JOIN US LIVE TOMORROW!

This educational webinar is supported by #Taudia.

#AlzheimersDisease #Biomarkers #ClinicalResearch #Neuroscience #MedicalEducation #ADPDEducation #ADPDonUNLOK

One month left to register and save up to €150!

Register for AD/PD™ 2027 by December 9, 2026, to benefit from the early registration rates.
From 16–20 March 2027, Barcelona will bring together researchers and clinicians for five days of new science, open debate, and connections that continue well beyond the conference.

Register today: adpd.kenes.com/register/

#ADPD2027 #AlzheimersResearch #ParkinsonsResearch #Neuroscience #Neurodegeneration